Myeloproliforative Disorder
A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared with Venetoclax Plus Acalabrutinib in Patients with Previously Untreated Chronic Lymphocytic Leukemia (BGB-11417-304)
- Details
ClinicalTrials.gov ID:
NCT07277231
Diagnosis Type:
NA
USOR Number:
- Address
,
P: